Results 61 to 70 of about 26,607 (119)

Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis: A GRADE-assessed systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Shah A, Khan S, Rizvi SVZ, Farhan K, Uddin M, Rizvi SUA, Fatima S, Karan AR, Khalid AA, Ali A, Ahmed S.   +10 more
europepmc   +1 more source

Postoperative bisphosphonate therapy is associated with lower prosthesis-related complications after total or reverse shoulder arthroplasty in osteoporotic patients: a TriNetX-based cohort study. [PDF]

BMC Musculoskelet Disord
Jao WY, Lai CC, Chien CS, Chang WS.
europepmc   +1 more source

Inflammation vs. multiple AVN sites: a nuclear medicine evaluation in systemic allergic-immune syndrome - a case report. [PDF]

Ann Med Surg (Lond)
Dhiman A, Karna R, Taggar M, Shamim SA.
europepmc   +1 more source

Anti-resorptive agents in neuroendocrine bone metastases - A systematic review. [PDF]

J Bone Oncol
Elston MS, Chan Chui C, Tamatea JAU, Lawrence B, Boyle V.   +4 more
europepmc   +1 more source

Characteristics and Risk Factors of Atypical Periprosthetic Femoral Fractures Following Total Hip Arthroplasty: A Systematic Review and Meta-Analysis. [PDF]

Arthroplast Today
Ade-Conde AM, Hamade A, Al-Mohrej O, Khanna V, Yan J.   +4 more
europepmc   +1 more source

Age-dependent musculoskeletal changes during mechanical unloading with bisphosphonate treatment. [PDF]

Bone
Orr SV, Gilmore NK, Pathak S, Edan HA, Langer H, Baar K, Christiansen BA.   +6 more
europepmc   +1 more source

Retrospective cohort study assessing radiological outcomes and risk factors for progression of femoral head osteonecrosis in children with sickle cell disease, following bisphosphonate therapy, CD-BMAC and proximal femoral reorientation osteotomy. [PDF]

J Child Orthop
Elayedatt RA, Gahukamble AD, A AM, Thuppale VE, Abraham A, Kandagaddala M, Palocaren T.   +6 more
europepmc   +1 more source

Investigation of Bisphosphonate Therapy for Osteoporosis: A Single-Center Cross-Sectional Study. [PDF]

J Gen Fam Med
Harada T, Kosaka S.
europepmc   +1 more source

Mind the gap: Adherence to denosumab dosing and cessation guidelines in Australian residential aged care. [PDF]

Br J Clin Pharmacol
O'Donnell M, Westbrook JI, Rahman B, Meulenbroeks I, Wabe N, Cameron ID, Morgan M, Raban MZ.   +7 more
europepmc   +1 more source

Intralesional Triamcinolone versus Oral Bisphosphonate for Benign Cystic Bone Lesions: A Prospective Comparative Study of Radiological and Pain Outcomes. [PDF]

J Orthop Case Rep
Kalme B, Kumar A, Gupta RK.
europepmc   +1 more source